Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Serum YKL-40, a potential inflammatory marker, is greatly increased at the early stage of ST-segment elevation myocardial infarction (STEMI). Here, we hypothesized that YKL-40 levels at admission could predict the long-term outcomes after STEMI. A total of 324 patients with acute STEMI undergoing pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Luyu, Dong, Hui, Lu, Huizhi, Liao, Youxia, Zhang, Hao, Xu, Lingwen, Tan, Yun, Cao, Song, Tan, Jinhui, Fu, Shouzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709285/
https://www.ncbi.nlm.nih.gov/pubmed/30896649
http://dx.doi.org/10.1097/MD.0000000000014920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709285/
https://www.ncbi.nlm.nih.gov/pubmed/30896649
http://dx.doi.org/10.1097/MD.0000000000014920

Ejemplares similares